Literature DB >> 32840315

Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report.

Fulvia Ceccarelli1, Silvia Mancuso1, Ramona Lucchetti1, Fabrizio Conti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 32840315     DOI： 10.1093/rheumatology/keaa389

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  2 in total

1.  Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus.

Authors:  Zsófia Király; Ágota Szepesi; Anna Sebestyén; Enikő Kuroli; Fanni Rencz; Béla Tóth; Laura Bokor; József Szakonyi; Márta Medvecz; Bernadett Hidvégi
Journal:  Pathol Oncol Res       Date:  2022-08-01       Impact factor: 2.874

2.  Successful Use of Immunotherapy in a Patient with Metastatic Squamous Cell Lung Cancer and Underlying Autoimmune Disease.

Authors:  Lusine Zakharian; Lauren Lee
Journal:  Cureus       Date:  2021-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.